Gurugram (Haryana) [India], May 12: Park Medi World Limited, North India's 2nd largest hospital chain (“the Company”) (NSE: PARKHOSPS, BSE: 544645) today announced its audited financial results for the quarter and year ended March 31st, 2026.
12M FY'26 HIGHLIGHTS
- Highest ever Revenue recorded of INR 16,794 mn, growth of 21% YoY
- Highest ever EBITDA recorded of INR 4,443 mn, growth of 20% YoY, with EBITDA margin of 26.5%
- Highest ever Net Profit recorded of INR 2,736 mn, growth of 27% YoY, with Net Profit margin of 16.3%, expansion of 83 bps YoY
- Cash from operations of INR 3,291 mn
- Significant reduction in debtor days from 161 days on 31.3.25 to 129 days on 31.3.26
- Negligible Term bank Debt of 282 mn as of 31st March 2026 (including INR 92 mn of current maturity of non-current bank debt)
- Total Debt at INR 2,279 mn (excluding lease liabilities) and INR 3,642 mn (including lease liabilities)
- Strong liquidity with INR 3,141 mn in Fixed Deposits. Total Cash & cash equivalent (including other balances) of INR 5,509 mn, resulting in Net Debt (excluding lease liabilities) of -3,230 mn (Net cash)
Growth Highlights
- 20% Capacity Addition— 610 beds added (highest in a year) through acquisitions in Bhatinda (250 beds) and Agra (360 beds, our largest acquisition till date), taking network capacity to 3,610 beds as of 31st March 2026
- Completed construction of our largest-ever greenfield hospital in Panchkula (350 beds) and its subsequent commissioning on 10th Apr'26, taking our total bed capacity to 3,960 beds as of date
- Announced the acquisition of Febris Multi-Speciality Hospital (200 beds) in Narela, Delhi, under the provisions of the Insolvency and Bankruptcy Code. The facility is expected to get commissioned in Q2 FY'27
- Announced 150-bed expansion at Mohali facility, taking total capacity to 500 beds; expected to be operational within 12–15 months, making the Company the largest private healthcare provider in the Tricity region.
Q4 FY'26 HIGHLIGHTS
- Highest ever Revenue recorded of INR 4,604 mn, growth of 30% YoY
- Highest ever EBITDA recorded of INR 1,274 mn, growth of 44% YoY, with EBITDA margin of 27.7%, growth of 268 bps YoY
- Highest ever Net Profit recorded of INR 768 mn, growth of 47% YoY, with Net Profit margin of 16.7%, growth of 188 bps YoY
KEY CONSOLIDATED FINANCIAL SUMMARY:
| Particulars | Q4 FY'26 | Q4 FY'25 | YoY% | 12M FY'26 | 12M FY'25 | YoY% | ||
| Financial Performance (INR mn) | ||||||||
| Revenue from Operations | 4,604 | 3,539 | 30% | 16,794 | 13,936 | 21% | ||
| EBITDA (ex-Other Income) | 1,274 | 884 | 44% | 4,443 | 3,710 | 20% | ||
| EBITDA Margin (%) | 27.7% | 25.0% | 268 bps | 26.5% | 26.6% | -16 bps | ||
| Net Profit | 768 | 524 | 47% | 2,736 | 2,154 | 27% | ||
| Net Profit Margin (%) | 16.7% | 14.8% | 188 bps | 16.3% | 15.5% | 83 bps | ||
| EPS (INR) | 1.78 | 1.36 | 31% | 6.87 | 5.60 | 23% | ||
| Gross Debt (including lease liabilities) | 3,642 | 6,821 | -47% | |||||
| Gross Debt (excluding lease liabilities) | 2,279 | 6,224 | -63% | |||||
| Cash & Cash Equivalent | 5,509 | 4,116 | 34% | |||||
| Net Debt (excluding lease liabilities) | -3,230 | 2,108 | -253% | |||||
| Cash from Operations | 3,291 | 2,154 | 53% | |||||
Commenting on the overall performance of the Company, Dr. Ajit Gupta, Chairman and Dr. Ankit Gupta, Managing Director, Park Medi World, said, “FY'26 was the finest year in Park Medi World’s history — a year in which we delivered record financial and operating performance, executed our largest-ever capacity addition, and strengthened our balance sheet, all simultaneously. That combination — growth, profitability, and financial discipline moving in the same direction at the same time — is the clearest possible validation of the model we have built over two decades.
Post our IPO, we remain firmly focused on disciplined capital allocation, balance sheet strength, and measured expansion. Our immediate priorities are the seamless integration of acquired assets, improving utilisation across newer facilities, and sustaining the profitability that funds our next phase of growth entirely through internal accruals. Over the medium term, we will continue to selectively pursue growth opportunities while maintaining our unwavering commitment to delivering affordable, high-quality healthcare and creating long-term value for all our stakeholders. The runway ahead has never been longer, and our conviction in what lies ahead has never been stronger.”
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor